Betaprol Injection contains Betamethasone 4mg/ml, a high-potency corticosteroid for controlling severe inflammation, allergic reactions, and autoimmune conditions. It works by suppressing overactive immune responses and reducing swelling, redness, and pain.
This injection is widely used for acute allergic reactions, arthritis flare-ups, asthma exacerbations, and dermatological conditions, ensuring rapid and effective symptom management.
For franchise partners, Betaprol Injection is a high-demand product in the anti-inflammatory and corticosteroid segment, providing strong prescriber confidence and repeat orders, enhancing portfolio strength.
With the growing need for advanced corticosteroid therapies, Betaprol Injection offers sustainable business growth opportunities, helping partners expand their presence in inflammation and allergy care segments.
Common side effects may include increased appetite, mood changes, headache, and mild gastrointestinal disturbances. Long-term or high-dose use may lead to elevated blood sugar, suppression of adrenal function, osteoporosis, or increased susceptibility to infections. Any severe or persistent side effects should be reported immediately to a healthcare professional.
Betaprol Injection is indicated for inflammatory and allergic conditions such as severe asthma, rheumatoid arthritis, skin disorders, allergic reactions, and certain autoimmune diseases. It may also be used to manage edema, shock, and other conditions where corticosteroid therapy is required under medical supervision.
Betaprol Injection should be administered strictly under medical supervision. It is contraindicated in patients with hypersensitivity to corticosteroids, systemic infections, or fungal infections. Caution is advised in patients with diabetes, hypertension, liver or kidney impairment, and in those receiving prolonged therapy.
Store Betaprol Injection in a cool, dry place below 25°C, protected from light. Keep out of reach of children and do not use after the expiry date indicated on the vial.